A new generation of AI-native researchers is leading the way in the war on cancer. This next crop of scientists is AI-native, interdisciplinary—and comfortable challenging assumptions. 

The New York-based safety net hospital has accused former CEO Megan Ryan of impropriety that includes paying out $3.5 million to herself and 12 other executives. She denies the allegations, and claims she is a whistleblower for fraud committed by the state.

The new drug, VTB-10, previously received the FDA's orphan drug designation in 2024.

Speaker issues are causing the devices to stop communicating with the user's CGM. Dozens of patient injuries have been reported, and the company is prepping a software update.

The therapy previously earned the FDA’s Breakthrough Device Designation due to its potential to treat certain cancers.

The agency recently issued a frequently asked questions fact sheet about the WISeR model days after House Democrats expressed concern about the initiative. 

Four men in Michigan have been charged and are accused of $1 million in fraud, in addition to the illegal distribution of controlled substances. The defendants include two physicians, a clinic manager and a patient recruiter.

New ACC/AHA recommendations encourage clinicians to take a proactive approach when managing patients with elevated or high blood pressure. The inclusion of renal denervation in this document represents clear progress for a relatively new technology.